Symetryx Corp

10% owner at NeuBase Therapeutics, Inc.

Sold, on record
$712k
Dollars the filings state
Form 4 sales
2
Latest Sep 18, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NeuBase Therapeutics, Inc.Unusual
    Sep 11, 2023 2023

    Sold 207,075 shares at $1.63 ($337k)

    Symetryx Corp, 10% owner

    No 10b5-1 planSold 30.5% of holdings ($1.1M position)472,926 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NeuBase Therapeutics, Inc.Unusual
    Sep 18, 2023 +7 days

    Sold 282,445 shares at $1.33 ($376k)

    Symetryx Corp, 10% owner

    No 10b5-1 planSold 100% of holdings ($376k position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Symetryx Corp
Source
Sep 18, 2023Sep 18, 2023NeuBase Therapeutics, Inc.10% ownerForm 4 sale282,445$376k100.0%UnusualSEC
Sep 11, 2023Sep 11, 2023NeuBase Therapeutics, Inc.10% ownerForm 4 sale207,075$337k30.5%UnusualSEC